Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference

TORONTO–(BUSINESS WIRE)–  Cybin Inc.  (NYSE American:CYBN) (Cboe CA:CYBN) (“  Cybin  ” or the “  Company  ”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to